Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02809716 · ClinicalTrials.gov registry record
High Definition Single Cell Analysis in Colorectal Cancer
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 24
- Enrollment target
NCT02809716: Completed study, sponsored by University of Southern California.
NCT02809716 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02809716 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This research clinical trial studies high definition single cell analysis in blood and tissue samples from patients with colorectal cancer which has spread to the liver. High definition single cell analysis allows doctors to study the properties of cancer cells that are sometimes found in the blood of patients and to determine how the genes and proteins in them may change over time. Studying samples from patients with colorectal cancer in the laboratory may help doctors learn more about how cancer spreads, as well as how to predict the disease outcomes in patients with cancer.
Primary Outcome
Biosignatures will be compared between cells from tumor tissue within the same patient, cells from blood samples within the same patient, cells from tumor tissue and blood samples within the same patient, cells from tumor tissue and blood samples across different patients. Upon these comparisons, biosignatures will be established which represent liquid and solid biopsy correlations for each patient and for the patient population. Descriptive statistics will be used to determine means, correlatio
Interventions
- OTHER Cytology Specimen Collection Procedure
- OTHER Biomarker Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-08-01 |
| Est. Completion | 2020-05-29 |
What the finished NCT02809716 record still lists
NCT02809716 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Cytology Specimen Collection Procedure is the first listed.
NCT02809716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02809716 about?
NCT02809716 is a clinical study titled "High Definition Single Cell Analysis in Colorectal Cancer". This research clinical trial studies high definition single cell analysis in blood and tissue samples from patients with colorectal cancer which has spread to the liver. High definition single cell analysis allows doctors to study the properties of cancer cells that are sometimes found in the blood ...
What is the current status of trial NCT02809716?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2016-08-01. Estimated completion is 2020-05-29.
What interventions are being tested in trial NCT02809716?
The interventions under investigation include: Cytology Specimen Collection Procedure (OTHER), Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT02809716?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI